Postpartum Hemorrhage: Enhancing Outcomes for Mothers by Effective Management
Author:
Open Access
- 27 June 2024
- journal article
- editorial
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 74 (3) , 191-195
Abstract
Postpartum hemorrhage (PPH) remains a significant contributor to maternal morbidity and mortality worldwide. In India, PPH affects approximately 12% of women. The prevention and management of PPH are the significant challenges in obstetrics, with accurate assessment of blood loss and timely intervention being critical. Active Management of the Third Stage of Labor is a gold standard strategy for prevention. Recent advancements in PPH management include the use of recombinant activated factor VIIa, which has shown promise in decreasing the need for invasive procedures and second-line therapies. Additionally, surgical and radiological interventions have been effective in cases of refractory PPH. Overall, ongoing research and advancements in PPH management continue to enhance the quality of care and maternal outcomes experiencing this potentially life-threatening complication of childbirth. This editorial explores prevention and management of Atonic PPH with encompassing medical and surgical strategies, to enhance understanding and optimize clinical care for mothers at risk of this obstetric emergency.Keywords
This publication has 14 references indexed in Scilit:
- Randomized Trial of Early Detection and Treatment of Postpartum HemorrhageNew England Journal of Medicine, 2023
- Epidemiology and definition of PPH worldwideBest Practice & Research Clinical Anaesthesiology, 2022
- FIGO recommendations on the management of postpartum hemorrhage 2022International Journal of Gynecology & Obstetrics, 2022
- Prevention of postpartum hemorrhageSeminars in Fetal and Neonatal Medicine, 2020
- Postpartum hemorrhage care bundles to improve adherence to guidelines: A WHO technical consultationInternational Journal of Gynecology & Obstetrics, 2019
- Tranexamic acid for post-partum haemorrhage: What, who and whenBest Practice & Research Clinical Obstetrics & Gynaecology, 2019
- Recombinant human FVIIa for reducing the need for invasive second‐line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trialJournal of Thrombosis and Haemostasis, 2015
- The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trialTrials, 2010
- Use of recombinant activated factor VII in massive postpartum haemorrhageEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2008
- Factors associated with acute postpartum hemorrhage in low-risk women delivering in rural IndiaInternational Journal of Gynecology & Obstetrics, 2008